Latest filing published 03 Mar 2023 for Albireo Pharma, INC..
No signal scores available.
David Chiswell discloses dealings in Albireo Pharma, Inc. to SEC (Form 4). Between 3 November 2016 and 2 March 2023, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 3 March 2023 came the latest disclosure, a transaction in Albireo Pharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations